top of page
ALKemist Bio
Next generation cell therapies for ALK-positive cancer patients
Our Vision
We aim to offer a cell therapy approach to target ALK-positive cancer cells, responsible for the acquisition of resistance and low progression-free survival of ALK-positive patients.
ALK positive tumors
ALK-positive (ALK+) cancer is mainly present in patients in the form of non-small cell lung cancer, but it can also originate in many other parts of the body, including the brain and breast.
​
ALK oncogene
Anaplastic lymphoma kinase (ALK) was originally discovered in 1994, in anaplastic large-cell lymphoma cells. An oncogene is a gene that is a mutated and is the main driver of cancer cells.
​
bottom of page